Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

  1. 12/9/13 12/9/13 - Martin Dugas
Uploaded on:

December 9, 2013

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00130858 # Soft Tissue Sarcoma


  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
age < 21
Soft tissue sarcoma chemosensible, stage IV
measurable tumor lesions
Exclusion criteria
Lack of cooperation by the patient
no willingness of follow-up examinations
participation on another clinical trial at the same time
death due to the sickness within four weeks
Medical Concepts

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial